World Institute of Pain

Meet Saluda Medical at the WIP Orlando Workshop 8-10 April

March 29, 2022

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain.

Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain.

Meet Saluda Medical at the WIP Orlando Workshop 8-10 April.

More info:

#wip #WorldInstituteOfPain #fippexam #cipsexam #wiporlando2022 #closedloop #scs #neuromodulation #ecaps #scsrevolution #evoke #chronicpain

The World Institute of Pain® is exempt from federal income tax under section 501(a) of the Internal Revenue Code as an
organization described in section 501(c)(3).

Federal ID No. 95‐4579119